IbrutinibiMpurityLDBX
97%
- Product Code: 201075
CAS:
1288338-96-4
| Molecular Weight: | 476.96 g./mol | Molecular Formula: | C₂₅H₂₅ClN₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used in the treatment of various B-cell malignancies including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. Acts as a potent inhibitor of Bruton's tyrosine kinase (BTK), which plays a crucial role in B-cell receptor signaling, leading to reduced proliferation and survival of malignant B cells. Also investigated for use in autoimmune diseases due to its modulation of immune cell activity. Employed in targeted cancer therapy with oral administration and has shown efficacy in patients with relapsed or refractory conditions.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50mg | 10-20 days | ฿14,250.00 |
+
-
|
IbrutinibiMpurityLDBX
Used in the treatment of various B-cell malignancies including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. Acts as a potent inhibitor of Bruton's tyrosine kinase (BTK), which plays a crucial role in B-cell receptor signaling, leading to reduced proliferation and survival of malignant B cells. Also investigated for use in autoimmune diseases due to its modulation of immune cell activity. Employed in targeted cancer therapy with oral administration and has shown efficacy in patients with relapsed or refractory conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :